Search

Zentalis Pharmaceuticals Inc

Fermé

3.87 -0.26

Résumé

Variation du prix de l'action

24h

Actuel

Min

3.82

Max

3.91

Chiffres clés

By Trading Economics

Revenu

-42M

-78M

BPA

-0.59

Employés

106

EBITDA

-42M

-77M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+126.99% upside

Dividendes

By Acuity

Prochains Résultats

6 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

25M

356M

Ouverture précédente

4.13

Clôture précédente

3.87

Zentalis Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

27 août 2026, 23:56 UTC

Robert Half Inc. shares are roughly flat in after-market hours amid mixed market sentiment and ongoing inflation concerns influencing Federal Reserve rate hike expectations.

27 août 2026, 23:56 UTC

Bright Horizons Family Solutions shares declined in after-market trading, despite remaining above their 20-day moving average amid mixed market sentiment and inflation concerns.

27 août 2026, 23:56 UTC

Correlated Moves

Rockwell Automation Inc shares are lower in after-market trading, reflecting broader market sentiment amid inflation data and expectations for a potential Federal Reserve rate hike.

27 août 2026, 23:56 UTC

Savara Inc shares are higher in after-market trading, despite no specific news. Broader market sentiment remains mixed amid ongoing inflation concerns and upcoming Fed guidance.

27 août 2026, 23:56 UTC

Entravision Communications Corp. shares remained roughly flat in after-market hours, with no specific news identified amid mixed market sentiment and inflation concerns.

27 août 2026, 23:56 UTC

Tennant Co. shares are lower in after-market trading, reflecting mixed market sentiment and ongoing inflation concerns influencing investor expectations for a Federal Reserve rate hike.

27 août 2026, 23:56 UTC

News Corp shares declined in after-market trading following Thursday's close, amid mixed market sentiment and inflation concerns ahead of Federal Reserve comments.

27 août 2026, 23:56 UTC

Coursera Inc. shares are lower in after-market hours, with no specific news identified. Market sentiment is mixed amid inflation concerns and Fed policy anticipation.

27 août 2026, 23:56 UTC

WEX Inc shares are lower in after-market hours with no specific news identified. Broader market sentiment is mixed amid ongoing inflation concerns.

27 août 2026, 23:56 UTC

Omnicell Inc. shares are higher in after-market trading, despite lacking specific company news. Recent economic data continues to influence market sentiment.

27 août 2026, 23:56 UTC

CVS Health shares are higher in after-market trading, recovering from an earlier dip. Market sentiment remains mixed amid ongoing inflation pressures in the U.S.

27 août 2026, 23:56 UTC

Shares of Martin Marietta Materials Inc. moved higher in after-market trading, maintaining gains since Thursday's close, though still below its 20-day moving average.

27 août 2026, 23:56 UTC

Correlated Moves
News

Royal Gold shares are higher in after-market trading following CEO Bill Heissenbuttel's upcoming presentation at the Jefferies Global Industrials Conference on September 10.

27 août 2026, 23:56 UTC

Correlated Moves
News

Diamondback Energy has risen in after-market hours following its joint venture for the Solitude Pipeline System, with analysts estimating a fair value of $232.17.

27 août 2026, 23:56 UTC

ETF Constituents

iShares MSCI Brazil ETF declines in after-market trading due to losses from key holdings VALE and PBR.A, despite mixed global equity sentiment.

27 août 2026, 23:56 UTC

Correlated Moves

Digital Realty Trust shares are lower in after-market trading, reflecting broader sector declines amid ongoing inflation concerns and anticipation of guidance from the Fed.

27 août 2026, 23:56 UTC

Coca-Cola Consolidated Inc shares are lower in after-market trading. No specific company news was identified to explain the decline amid mixed market sentiment.

27 août 2026, 23:56 UTC

EUR/DKK trading roughly flat as mixed sentiment persists amid ongoing inflation concerns and expectations for a Federal Reserve rate hike ahead of Jackson Hole.

27 août 2026, 23:52 UTC

Mexican Consumer Confidence Index Set for Release Amid Mixed Market Sentiment and Ongoing Economic Challenges.

27 août 2026, 23:52 UTC

Japan's July unemployment rate drops to 2.4%, beating forecasts and signaling economic resilience despite inflation concerns.

27 août 2026, 23:52 UTC

ADP Employment Change Report on September 2, 2026, Expected to Reveal Slowing Job Growth Amid Economic Uncertainty.

27 août 2026, 23:52 UTC

Anticipation Builds for Fed Chair Kevin Warsh's Keynote at Jackson Hole Symposium Amid Inflation Concerns and Interest Rate Speculations.

27 août 2026, 23:51 UTC

U-Haul Holding Co shares are lower in after-market hours, continuing a seven-session decline amid broader market dynamics and recent economic data on the labor market.

27 août 2026, 23:51 UTC

Transcat Inc shares are trading lower in after-market hours, with no specific news identified to explain the decline. The stock remains below its 20-day moving average.

27 août 2026, 23:51 UTC

Insperity Inc. shares are lower in after-market trading, reflecting stability amid broader market dynamics with no specific news identified.

27 août 2026, 23:51 UTC

Evertec Inc shares are lower in after-market hours, reflecting broader market trends. Rising Treasury yields and economic data contribute to the downward pressure.

27 août 2026, 23:51 UTC

Science Applications International Corp. shares are higher in after-market hours, continuing an upward trend since Thursday's close and remaining above the 20-day moving average.

27 août 2026, 23:51 UTC

Trinity Industries Inc shares are lower in after-market hours, continuing a trend of declines over the past three sessions without any specific news identified.

27 août 2026, 23:51 UTC

Yelp Inc shares are lower in after-market hours amid broader market declines. Economic data and geopolitical tensions contribute to negative sentiment in equity markets.

27 août 2026, 23:51 UTC

SLM Corp shares are lower in after-market trading amid a broader market decline and rising Treasury yields, reflecting cautious investor sentiment.

Comparaison

Variation de prix

Zentalis Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

126.99% hausse

Prévisions sur 12 Mois

Moyen 8.83 USD  126.99%

Haut 11 USD

Bas 5 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

6 ratings

5

Achat

1

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products candidatures include the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase for the treatment of inhibitor for advanced solid tumors and hematological malignancies; in Phase 2 clinical trial as a monotherapy for the treatment of uterine serous carcinoma indications; Phase 2 clinical trial in Cyclin E1 driven high-grade serous ovarian cancer, fallopian tube, or primary peritoneal cancer; Phase 1/2 clinical trial in combination with PARPi for platinum-resistant ovarian cancer; Phase 1b clinical trial in combination with chemotherapy in platinum-resistant ovarian, and peritoneal or fallopian tube cancer; Phase 1/2 clinical trial in combination with chemotherapy in relapsed or refractory osteosarcoma; Phase 1/2 clinical trial with encorafenib and cetuximab for mutant metastatic colorectal cancer; and Phase 1/2 clinical trial in combination with chemotherapy in pancreatic cancer. The company's products pipeline also includes ZN-d5, an oral small molecule inhibitor of B-cell lymphoma 2, for hematological malignancies and related disorders; and BCL-xL heterobifunctional degrader, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Pfizer, Inc.; Zentera Therapeutics; Dana-Farber; and GlaxoSmithKline plc. The company was incorporated in 2014 and is headquartered in New York, New York.
help-icon Live chat